Expansion Of The Genetic Surveillance State: Taking The Blood Of Babies Born To Mississippi Teens
By Kashmir Hill,
Forbes
| 07. 02. 2013
In what sounds like a plot twist from a dystopic-future novel, Mississippi
is now requiring hospitals to store the blood of babies born to mothers 16 and younger. The
new law, which went into effect on Monday, July 1, is meant to discourage teen pregnancy, according to its drafters, but in a very roundabout way.
Any time a teen mom doesn’t know who the father is, or won’t say who the father is, or says the father is over 21, a hospital is required to take a blood sample from the baby’s umbilical cord and put it on ice. DNA will then be extracted from that blood and used to hunt down the (presumably) older men who had sex with the young women. They can be charged with statutory rape if they are more than 3 years older than the under-16 moms. The state hopes this will discourage cradle-robbers/cradle-makers in the future.
Via
NPR:
Starting in July, doctors and midwives in the state will be required by law to collect samples of umbilical cord blood from babies born...
Related Articles
It’s been a busy couple of months in biopolitics, with developments in the US, UK, China, Japan, and implicitly on Mars. Time for a brief roundup.
• • •
Bioethics needs an update
The National Research Act is now 50 years old. It was signed into law on July 12, 1974, as a direct response to publicity about the 1932 “Tuskegee Study of Untreated Syphilis in the Negro Male.” The Hastings Bioethics Forum celebrated its anniversary with an...
By Robert Resta, The DNA Exchange | 07.22.2024
Medical geneticists and genetic counselors have an often complicated and at times tense relationship with people with disabilities, their families, advocates, and scholars. Geneticists are strong advocates and supporters for all of their patients, regardless of their abilities and disabilities...
By Katherine Bourzac, Nature | 07.10.2024
Image courtesy National Human Genome Research Institute
The U.S. Food and Drug Administration (FDA) is supposed to encourage effective medical advances while also ensuring that patients and research subjects are protected. This dual mandate demands tricky judgment calls that are made more difficult by outside pressures of several kinds, political, judicial, and especially commercial. This April story at Bloomberg examines one deeply troubling pattern of regulatory capture:
Americans Are Paying Billions to Take Drugs That Don’t Work
Companies are increasingly...